MABVAX THERAPEUTICS HOLDINGS, INC. — Form D

MABVAX THERAPEUTICS HOLDINGS, INC. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-15. The offering totals $860K, of which $830K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
Kenneth M CohenDirectorSAN DIEGO, CA
Jeffrey F EisenbergDirectorSan Diego, CA
J. David HansenDirectorSan Diego, CA
Philip O LivingstonDirectorSan Diego, CA
Paul V MaierDirectorDeer Park, IL
Thomas C VarvaroDirectorSan Diego, CA
J. David HansenExecutive OfficerSan Diego, CA
Gregory P HansonExecutive OfficerSan Diego, CA
Paul W MaffuidExecutive OfficerSan Diego, CA
Paul W ResnickExecutive OfficerSan Diego, CA
Robert HoffmanDirectorHouston, TX
Paul ResnickExecutive OfficerLexington, MA
Jeffrey EisenbergDirectorFramingham, MA
Paul MaierDirectorEL CAJON, CA
THOMAS VARVARODirectorIRVINE, CA
Philip O LivingstonExecutive OfficerSan Diego, CA
Philip LivingstonDirectorSan Diego, CA
Kenneth CohenDirectorSan Diego, CA
Gregory HansonDirectorSan Diego, CA
Gregory HansonExecutive OfficerSan Diego, CA
Paul MaffuidExecutive OfficerSan Diego, CA
Jeffrey RavetchDirectorSan Diego, CA
Thomas VarranoDirectorSan Diego, CA
Jeffrey V RavetchDirectorSan Diego, CA
J. David HansenDirectorSan Diego, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2018-02-13D$2.8M$2.8M
2015-04-09D$15.0M$11.6M
2014-07-10D$5.2M$5.2M
2014-05-22D$4.6M$4.6M

More